Purpose Correct diagnosis, surgical treatment, and perioperative management of patients
with esophageal carcinoma remain crucial for prognosis within multimodal treatment …

Background An increasing incidence of adenocarcinoma, a modified surgical strategy and
the increasing use of multimodal therapeutic protocols have had a major impact on the …

Esophageal cancer is a virulent malignancy associated with a 5-year overall survival of
approximately 5%. Treatment remains controversial—despite the results of prospective …

The terminology used to describe esophagectomy for carcinoma can be confusing, even for
specialists in gastrointestinal disease. As a result, specific terms are often used out of their …

The outcome of esophagectomy could be improved by optimal diagnostic strategies leading
to adequate preoperative patient selection. Neoadjuvant therapy could improve outcome by …

Surgery for esophageal cancer remains a cornerstone for early stage disease. The treatment
of more advanced locoregional disease is quite controversial. Efforts to improve survival in …

Background Esophageal resection (ER) remains the standard therapy for early esophageal
cancer; however, because of concerns regarding high levels of morbidity and mortality …

In the past few years, major improvements and new technologies have been proposed and
applied in esophageal surgery. Its evolution depended not only on a thorough knowledge of …

Background: This review depicts surgical treatment strategies in the management of
esophageal cancer under the focus of evidence-based medicine. The main emphasis lies …

Esophageal cancer is an aggressive disease with an overall poor prognosis.
Esophagectomy remains a key therapeutic option in treating patients who have this disease …